Novartis AG Increase Decrease Through Transfers And Other Changes Equity
Novartis AG (NVSEF) reported Increase Decrease Through Transfers And Other Changes Equity of $100.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity · last filed 2026-02-04
- Novartis AG increase decrease through transfers and other changes equity for the quarter ending 2025-06-30 was $23.00M, a 52.08% decline year-over-year.
- Novartis AG increase decrease through transfers and other changes equity for the quarter ending 2024-06-30 was $48.00M, a 118.18% increase year-over-year.
- Novartis AG increase decrease through transfers and other changes equity for the quarter ending 2023-06-30 was $22.00M, a 81.20% decline year-over-year.
- Novartis AG increase decrease through transfers and other changes equity for the quarter ending 2022-06-30 was $117.00M, a 735.71% increase year-over-year.
| Period end | Increase Decrease Through Transfers And Other Changes Equity 3 month | Increase Decrease Through Transfers And Other Changes Equity 6 month | Increase Decrease Through Transfers And Other Changes Equity 12 month |
|---|---|---|---|
| 2025-12-31 | $100.00M 20-F · filed 2026-02-04 | ||
| 2025-06-30 | $23.00M 6-K · filed 2025-07-17 | $67.00M 6-K · filed 2025-07-17 | |
| 2024-12-31 | $154.00M 20-F · filed 2026-02-04 | ||
| 2024-06-30 | $48.00M 6-K · filed 2025-07-17 | $114.00M 6-K · filed 2025-07-17 | |
| 2023-12-31 | $129.00M 20-F · filed 2026-02-04 | ||
| 2023-06-30 | $22.00M 6-K · filed 2024-07-18 | $58.00M 6-K · filed 2024-07-18 | |
| 2022-12-31 | $217.00M 20-F · filed 2025-01-31 | ||
| 2022-06-30 | $117.00M 6-K · filed 2023-07-18 | $140.00M 6-K · filed 2023-07-18 | |
| 2021-12-31 | $48.00M 20-F · filed 2024-01-31 | ||
| 2021-06-30 | $14.00M 6-K · filed 2022-07-19 | $27.00M 6-K · filed 2022-07-19 | |
| 2020-12-31 | $18.00M 20-F/A · filed 2023-05-15 | ||
| 2020-06-30 | $4.00M 6-K · filed 2021-07-21 | $9.00M 6-K · filed 2021-07-21 | |
| 2019-12-31 | $22.00M 20-F · filed 2022-02-02 | ||
| 2019-06-30 | $7.00M 6-K · filed 2020-07-21 | $13.00M 6-K · filed 2020-07-21 | |
| 2018-12-31 | $38.00M 20-F · filed 2021-01-26 |